Cell therapy for ischaemic stroke

Cell Proliferation

Volumn 44, Issue SUPPL. 1, 2011, Pages 1-8

  Hess, D C ^a   Hill, W D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CXCR4; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOKINE; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENEIC STEM CELL TRANSPLANTATION; APHASIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; CARCINOGENESIS; CELL MIGRATION; CELL THERAPY; CELL TYPE; CLINICAL TRIAL (TOPIC); DIFFUSION TENSOR IMAGING; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; UMBILICAL CORD BLOOD; UPREGULATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; HUMANS; STROKE; TISSUE THERAPY;

ANIMALIA;

EID: 79953838912     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00718.x     Document Type: Article

References (63)

1. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D et al. (2008) Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317-1329.
2. Duggal N, Schmidt-Kastner R, Hakim AM (1997) Nestin expression in reactive astrocytes following focal cerebral ischemia in rats. Brain Res. 768, 1-9.
3. Li Y, Chopp M (1999) Temporal profile of nestin expression after focal cerebral ischemia in adult rat. Brain Res. 838, 1-10.
4. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8, 963-970.
5. Thored P, Arvidsson A, Cacci E, Ahlenius H, Kallur T, Darsalia V et al. (2006) Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 24, 739-747.
6. Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D et al. (2004) SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 63, 84-96.
7. Ohab JJ, Fleming S, Blesch A, Carmichael ST (2006) A neurovascular niche for neurogenesis after stroke. J. Neurosci. 26, 13007-13016.
8. Dancause N, Barbay S, Frost SB, Plautz EJ, Chen D, Zoubina EV et al. (2005) Extensive cortical rewiring after brain injury. J. Neurosci. 25, 10167-10179.
9. Bogousslavsky J, Victor SJ, Salinas EO, Pallay A, Donnan GA, Fieschi C et al. (2002) Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial. Cerebrovasc. Dis. 14, 239-251.
10. Shyu WC, Lin SZ, Yang HI, Tzeng YS, Pang CY, Yen PS et al. (2004) Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 110, 1847-1854.
11. Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R et al. (2005) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115, 2083-2098.
12. Kawada H, Takizawa S, Takanashi T, Morita Y, Fujita J, Fukuda K et al. (2006) Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113, 701-710.
13. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C et al. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97, 10526-10531.
14. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35, 1732-1737.
15. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8, 495-505.
16. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K et al. (2009) Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40, e647-e656.
17. Cramer SC, Fitzpatrick C, Warren M, Hill MD, Brown D, Whitaker L et al. (2010) The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial. Stroke 41, 927-931.
18. Doggrell SA (2004) A neuroprotective derivative of erythropoietin that is not erythropoietic. Expert Opin. Investig. Drugs 13, 1517-1519.
19. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ (1998) Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA 95, 3908-3913.
20. Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98, 1076-1084.
21. Wang L, Li Y, Chen J, Gautam SC, Zhang Z, Lu M et al. (2002) Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp. Hematol. 30, 831-836.
22. Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB et al. (2005) Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp. Neurol. 195, 16-26.
23. Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H et al. (2006) Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 129, 2734-2745.
24. Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD (2005) I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136, 161-169.
25. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822.
26. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H et al. (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214-2219.
27. Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M (2001) Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 189, 49-57.
28. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M et al. (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005-1011.
29. Li Y, Chen J, Wang L, Lu M, Chopp M (2001) Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56, 1666-1672.
30. Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A et al. (2006) Therapeutic benefit of bone marrow stromal cells administered 1month after stroke. J. Cereb. Blood Flow Metab. 27, 6-13.
31. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC et al. (2003) Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 92, 692-699.
32. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D et al. (2003) Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res. 73, 778-786.
33. McGuckin CP, Forraz N, Baradez MO, Navran S, Zhao J, Urban R et al. (2005) Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. 38, 245-255.
34. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N et al. (2004) A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 200, 123-135.
35. Kucia M, Reca R, Campbell FR, Zuba-Surma E, Majka M, Ratajczak J et al. (2006) A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 20, 857-869.
36. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR (2004) Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35, 2385-2389.
37. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE et al. (2001) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682-2688.
38. Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T et al. (2004) Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35, 2390-2395.
39. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H et al. (2004) Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114, 330-338.
40. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S et al. (2003) Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 73, 296-307.
41. Newcomb JD, Ajmo CT Jr, Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE (2006) Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 15, 213-223.
42. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM (2002) Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 30, 896-904.
43. Jiang Y, Henderson D, Blackstad M, Chen A, Miller RF, Verfaillie CM (2003) Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc. Natl. Acad. Sci. USA 100(Suppl. 1), 11854-11860.
44. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49.
45. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC (2002) Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174, 11-20.
46. Mays R, Borlongan CV, Yasuhara T, Hara K, Maki M, Carroll JE et al. (2010) Development of an allogeneic adherent stem cell therapy for treatment of ischemic stroke. J. Exp. Stroke Transl. Med. 3, 34-46.
47. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI et al. (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18, 683-692.
48. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD (2006) Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 26, 654-665.
49. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A et al. (2006) Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 176, 6523-6531.
50. Schwarting S, Litwak S, Hao W, Bahr M, Weise J, Neumann H (2008) Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 39, 2867-2875.
51. Vendrame M, Gemma C, Pennypacker KR, Bickford PC, Davis Sanberg C, Sanberg PR et al. (2006) Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp. Neurol. 199, 191-200.
52. Bang OY, Lee JS, Lee PH, Lee G (2005) Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57, 874-882.
53. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY (2010) A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 6, 1099-1106.
54. Barbosa da Fonseca LM, Gutfilen B, Rosado de Castro PH, Battistella V, Goldenberg RC, Kasai-Brunswick T et al. (2010) Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp. Neurol. 221, 122-128.
55. Duncan PW, Goldstein LB, Matchar D, Divine GW, Feussner J (1992) Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke 23, 1084-1089.
56. Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J et al. (2000) Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55, 565-569.
57. Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR (1998) Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp. Neurol. 149, 310-321.
58. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J et al. (2005) Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J. Neurosurg. 103, 38-45.
59. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR (2005) Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc. Dis. 20, 101-107.
60. Stroemer P, Hope A, Patel S, Pollock K, Sinden J (2008) Development of a human neural stem cell line for use in recovery from disability after stroke. Front. Biosci. 13, 2290-2292.
61. Zhong J, Chan A, Morad L, Kornblum HI, Fan G, Carmichael ST (2010) Hydrogel matrix to support stem cell survival after brain transplantation in stroke. Neurorehabil. Neural Repair 24, 636-644.
62. Jin K, Mao X, Xie L, Galvan V, Lai B, Wang Y et al. (2010) Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J. Cereb. Blood Flow Metab. 30, 534-544.
63. Kawai H, Yamashita T, Ohta Y, Deguchi K, Nagotani S, Zhang X et al. (2010) Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J. Cereb. Blood Flow Metab. 30, 1487-1493.